Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein C and hypertension.

M Penka1, M Parizek, S Cronberg

  • 1Second Clinic of Internal Medicine, University Hospital, Brno-Bohunice, Czechoslovakia.

Nouvelle Revue Francaise D'Hematologie
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increasing procoagulant activity of circulating microparticles in patients living with HIV.

Medecine et maladies infectieuses·2019
Same author

High Level of Circulating Microparticles in Patients with BCR/ABL Negative Myeloproliferative Neoplasm - a Pilot Study.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2019
Same author

Spontaneous retroperitoneal hematoma - our experience with surgical approach.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2019
Same author

Patterns in anticoagulant utilization in the Czech Republic during 2007-2017.

Journal of thrombosis and thrombolysis·2019
Same author

Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Biobanking - the First Step to Successful Liquid Biopsy Experiments.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2017
Same journal

XIVth Congress of the French Society of Hematology. Paris, France, February 3-4, 1995. Abstracts.

Nouvelle revue francaise d'hematologie·1995
Same journal

Improved detection of CD2 on formaldehyde-fixed non dehydrated cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation.

Nouvelle revue francaise d'hematologie·1995
Same journal

Allogeneic transplantation of peripheral blood progenitor cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Selection and expansion of CD34+ cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Ex vivo hematopoietic cell expansion: a theoretical and technological challenge.

Nouvelle revue francaise d'hematologie·1995
See all related articles

Essential hypertension patients showed normal levels of Protein C antigen and amidolytic activity. Early-stage disease did not reveal any abnormalities compared to healthy individuals.

Area of Science:

  • Biochemistry
  • Hematology
  • Cardiovascular Medicine

Background:

  • Essential hypertension is a common cardiovascular condition.
  • Protein C is a crucial anticoagulant protein.
  • Understanding coagulation markers in hypertension is important.

Purpose of the Study:

  • To investigate Protein C antigen and amidolytic activity in patients with essential hypertension.
  • To compare these levels with those of healthy individuals.

Main Methods:

  • Assayed Protein C antigen levels.
  • Measured Protein C amidolytic activity.
  • Included 38 patients with first-stage essential hypertension and 20 healthy blood donors.

Main Results:

Related Experiment Videos

  • No significant abnormalities were found in Protein C antigen levels.
  • No significant abnormalities were found in Protein C amidolytic activity.
  • Results were comparable between hypertensive patients and healthy controls.

Conclusions:

  • Early-stage essential hypertension does not appear to affect Protein C antigen or amidolytic activity.
  • Protein C function may not be directly implicated in the initial stages of essential hypertension.